These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 27904273)
1. Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study. Youn HJ; Kim SY; Park M; Jung WH; Lee YW; Choe YB; Ahn KJ Ann Dermatol; 2016 Dec; 28(6):733-739. PubMed ID: 27904273 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of novel cosmetic shampoo formulations against Malassezia species: Preliminary results of anti-dandruff shampoo formulations. Ergin Ç; Kurt Ö; Türkoğlu M; Sevinç H; Akbaba G J Cosmet Dermatol; 2024 Jun; 23(6):2078-2083. PubMed ID: 38544350 [TBL] [Abstract][Full Text] [Related]
4. Facial Seborrheic Dermatitis in HIV-Seropositive Patients: Evaluation of the Efficacy and Safety of a Non-Steroidal Cream Containing Piroctone Olamine, Biosaccharide Gum-2 and Stearyl Glycyrrhetinate - A Case Series. Cortés-Correa C; Piquero-Casals J; Chaparro-Reyes D; Garré Contreras A; Granger C; Peñaranda-Contreras E Clin Cosmet Investig Dermatol; 2022; 15():483-488. PubMed ID: 35330623 [TBL] [Abstract][Full Text] [Related]
5. Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face. Puviani M; Campione E; Offidani AM; De Grandi R; Bianchi L; Bobyr I; Giannoni M; Campanati A; Bottagisio M; Bidossi A; De Vecchi E; Eisendle K; Milani M Clin Cosmet Investig Dermatol; 2019; 12():285-293. PubMed ID: 31190937 [No Abstract] [Full Text] [Related]
6. Distribution of malassezia species on the scalp in korean seborrheic dermatitis patients. Lee YW; Byun HJ; Kim BJ; Kim DH; Lim YY; Lee JW; Kim MN; Kim D; Chun YJ; Mun SK; Kim CW; Kim SE; Hwang JS Ann Dermatol; 2011 May; 23(2):156-61. PubMed ID: 21747613 [TBL] [Abstract][Full Text] [Related]
7. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography. Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Schmidt-Rose T; Braren S; Fölster H; Hillemann T; Oltrogge B; Philipp P; Weets G; Fey S Int J Cosmet Sci; 2011 Jun; 33(3):276-82. PubMed ID: 21272039 [TBL] [Abstract][Full Text] [Related]
9. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris. Kaewsanit T; Chakkavittumrong P; Waranuch N J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354 [TBL] [Abstract][Full Text] [Related]
10. Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis. Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Granger C; Micali G Clin Cosmet Investig Dermatol; 2019; 12():103-108. PubMed ID: 30774406 [TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains. Roques C; Brousse S; Panizzutti C Mycopathologia; 2006 Dec; 162(6):395-400. PubMed ID: 17146583 [TBL] [Abstract][Full Text] [Related]
12. Non-Steroidal Topical Therapy for Facial Seborrheic Dermatitis. Piquero-Casals J; La Rotta-Higuera E; Francisco Mir-Bonafé J; Rozas-Muñoz E; Granger C J Drugs Dermatol; 2020 Jun; 19(6):658-660. PubMed ID: 32574015 [TBL] [Abstract][Full Text] [Related]
13. Exploring Anti-Fungal, Anti-Microbial and Anti-Inflammatory Properties of a Topical Non-Steroidal Barrier Cream in Face and Chest Seborrheic Dermatitis. Balato A; Caiazzo G; Di Caprio R; Scala E; Fabbrocini G; Granger C Dermatol Ther (Heidelb); 2020 Feb; 10(1):87-98. PubMed ID: 31705438 [TBL] [Abstract][Full Text] [Related]
14. Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production. Kim SY; Kim SH; Kim SN; Kim AR; Kim YR; Kim MJ; Park WS; Lee JH; Jung WH; Lee YW; Choe YB; Ahn KJ Mycoses; 2016 May; 59(5):274-80. PubMed ID: 26786542 [TBL] [Abstract][Full Text] [Related]
15. [Malassezia species in patients with seborrheic dermatitis and atopic dermatitis]. Tajima M Nihon Ishinkin Gakkai Zasshi; 2005; 46(3):163-7. PubMed ID: 16094289 [TBL] [Abstract][Full Text] [Related]
16. Treatment of cradle cap in infants with a new cosmetic non-steroidal gel cream: Clinical, laboratory, and instrumental evaluation. Micali G; Pulvirenti N; Dall'Oglio F; Tedeschi A; Quattrocchi E; Lacarrubba F J Cosmet Dermatol; 2021 Apr; 20 Suppl 1(Suppl 1):14-17. PubMed ID: 33934474 [TBL] [Abstract][Full Text] [Related]
17. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis. Elewski BE; Cantrell WC J Drugs Dermatol; 2011 Aug; 10(8):895-9. PubMed ID: 21818511 [TBL] [Abstract][Full Text] [Related]
18. An Overview of the Diagnosis and Management of Seborrheic Dermatitis. Dall'Oglio F; Nasca MR; Gerbino C; Micali G Clin Cosmet Investig Dermatol; 2022; 15():1537-1548. PubMed ID: 35967915 [TBL] [Abstract][Full Text] [Related]
19. [Prevalence of Malassezia species associated with seborrheic dermatitis lesions in patients in Argentina]. Sosa Mde L; Rojas F; Mangiaterra M; Giusiano G Rev Iberoam Micol; 2013; 30(4):239-42. PubMed ID: 23500158 [TBL] [Abstract][Full Text] [Related]
20. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. Elewski B Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]